Health Affairs August 27, 2021
The COVID-19 pandemic has increased the public’s awareness of the need for high-quality, safe, and effective pharmaceutical products. Many have been surprised to learn of the US’s dependence on a highly globalized and largely opaque pharmaceutical supply chain.
Yet, even before the COVID-19 pandemic, dozens, and sometimes hundreds, of prescription pharmaceutical products went into shortage every year. Drug shortages have caused disruptions in how patient care is provided and imposed significant costs on the operations of pharmacies, hospitals, and health care systems. Some have even led to adverse outcomes for patients.
To address perceived shortcomings in the US prescription drug supply chain, the White House issued a report in June 2021 entitled “Building Resilient Supply Chains, Revitalizing American Manufacturing,...
Today's Sponsors
Today's Sponsor